Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

95
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
95
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

1.4K
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
1.4K
Pharmacodynamic Models: Emax Drug–Concentration Effect Model01:18

Pharmacodynamic Models: Emax Drug–Concentration Effect Model

202
The Emax drug-concentration effect model is central to pharmacodynamics in drug discovery and development. This model is predicated on the receptor occupancy theory, which posits that the effect of a drug is directly related to the number of receptors occupied by the drug and the resultant complex formation.The model describes the reversible interaction between a drug (C) and a receptor (R) to form a drug-receptor complex (RC). The kinetics of this interaction are quantified by an equation that...
202
Protein Networks02:26

Protein Networks

4.7K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.7K
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model01:29

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

142
Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
142
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

8.0K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
8.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation and improvement of two European soybean VCU networks.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2026
Same author

Balancing Savanna Ungulate Diversity and Biomass: Optimal Human Use, Landscape Features, and Vegetation Types Under Varying Rainfall and Land Use.

Ecology and evolution·2026
Same author

Correction: Regression approaches for modeling genotype‑environment interaction and making predictions into unseen environments.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2026
Same author

Regression approaches for modeling genotype-environment interaction and making predictions into unseen environments.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2026
Same author

Exploring intra-varietal variation for complex traits in grapevine (Vitis vinifera L.).

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2025
Same author

Hierarchical Bayesian Integrated Modeling of Age- and Sex-Structured Wildlife Population Dynamics.

Journal of agricultural, biological, and environmental statistics·2025
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
Same journal

Moving From Individualized Risk-Based Prevention to Benefit-Based Prevention: Estimating Individualized Life-Years Gained From Prevention Services as a Basis for Eligibility.

Statistics in medicine·2026
See all related articles

Related Experiment Video

Updated: Apr 20, 2026

Quantification of Protein Interaction Network Dynamics using Multiplexed Co-Immunoprecipitation
07:57

Quantification of Protein Interaction Network Dynamics using Multiplexed Co-Immunoprecipitation

Published on: August 21, 2019

9.4K

Multiplicative interaction in network meta-analysis.

Hans-Peter Piepho1, Laurence V Madden, Emlyn R Williams

  • 1Biostatistics Unit, Institute of Crop Science, University of Hohenheim, Fruwirthstrasse 23, Stuttgart, 70599, Germany.

Statistics in Medicine
|November 21, 2014
PubMed
Summary
This summary is machine-generated.

This study introduces multiplicative models for meta-analysis, moving beyond simple additive effects. These models better capture treatment-trial interactions and reveal treatment effect sensitivity across studies.

Keywords:
analysis of variance (ANOVA)contrastheterogeneityinconsistencyjoint regression analysislinear mixed modelmultiplicative interaction

More Related Videos

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.8K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.4K

Related Experiment Videos

Last Updated: Apr 20, 2026

Quantification of Protein Interaction Network Dynamics using Multiplexed Co-Immunoprecipitation
07:57

Quantification of Protein Interaction Network Dynamics using Multiplexed Co-Immunoprecipitation

Published on: August 21, 2019

9.4K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.8K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.4K

Area of Science:

  • Biostatistics
  • Clinical Epidemiology
  • Statistical Modeling

Background:

  • Traditional meta-analysis often assumes additive treatment and trial effects, which can be an oversimplification.
  • Additive models may not fully capture the nuanced interplay between treatment efficacy and study-specific characteristics.

Purpose of the Study:

  • To develop and evaluate meta-analysis models incorporating multiplicative terms for treatment-trial interactions.
  • To demonstrate how these models offer deeper insights into treatment effect heterogeneity and trial-specific influences.

Main Methods:

  • Utilized a two-way analysis-of-variance framework for meta-analysis.
  • Incorporated fixed or random effects for trials within the multiplicative modeling approach.
  • Applied the models to two distinct examples to assess their performance and interpretability.

Main Results:

  • Multiplicative models demonstrated a superior fit compared to purely additive models in the analyzed examples.
  • These models provided valuable information regarding the sensitivity of treatment effects to variations across trials.
  • The study successfully illustrated the utility of multiplicative terms for modeling statistical inconsistency in meta-analysis.

Conclusions:

  • Multiplicative models offer a more sophisticated approach to meta-analysis, enhancing the understanding of treatment-by-trial interactions.
  • These advanced models provide richer insights into the sources of heterogeneity and inconsistency in clinical trial data.
  • The proposed methodology improves the assessment of treatment effect variability across different study contexts.